You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pituitary ACTH Hypersecretion

Showing 1 - 25 of 923
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cushing's Disease Trial run by the NINDS (Vorinostat)

Recruiting
  • Cushing's Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Pituitary Tumors and Related Hypothalmic Disorders

Recruiting
  • Panhypopituitarism
  • +3 more
  • MRI
  • Tissue specimen collection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

Recruiting
  • Cushing Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)

    Not yet recruiting
    • Cushing's Disease
    • Pituitary Adenoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)

    Recruiting
    • Cushing Syndrome
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health (NIH) - National Institute of Diab
    Mar 27, 2023

    Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)

    Completed
    • Pituitary ACTH Hypersecretion
    • +3 more
    • Cholecalciferol 15000 UNT/ML Oral Solution
    • Moscow, Russian Federation
      Endocrinology Research Centre, Moscow
    Aug 10, 2022

    Cushing Disease Trial in Los Angeles (Seliciclib)

    Active, not recruiting
    • Cushing Disease
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 24, 2022

    Cushing Disease, DVT, Pulmonary Embolism Trial in China (LMWH/Rivaroxaban, IPC)

    Recruiting
    • Cushing Disease
    • +2 more
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 10, 2022

    Cushings Disease Trial in Los Angeles (R-roscovitine)

    Terminated
    Has Results
    • Cushings Disease
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Nov 1, 2021

    Discriminant Capacity and Thresholds of Salivary Cortisol in

    Recruiting
    • Cushing Disease
    • Blood test
    • +3 more
    • Nîmes, France
      CHU de Nimes
    Oct 4, 2021

    Patients With Cushing's Syndrome

    Recruiting
    • Cushing's Disease
    • +2 more
    • Cushing's QoL (Quality of Life Questionnaire)
    • +10 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 13, 2023

    Novel Mediators of Lipodystrophy and Metabolic Consequences of

    Completed
    • Cushing's Syndrome
    • Treatment of Cushing's
    • New York, New York
      Columbia University Neuroendocrine Unit
    Jul 12, 2021

    Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)

    Recruiting
    • Cushing Disease
    • Patient group
    • +2 more
    • Caen, France
    • +6 more
    Dec 16, 2021

    Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)

    Completed
    • Iatrogenic Cushing's Disease
    • AZD4017 and prednisolone
    • Placebo Oral Tablet and prednisolone
    • Oxford, United Kingdom
      University of Oxford
    May 12, 2021

    Cushing's Disease Trial in Bron ([11C]-Methionine PET/MRI)

    Completed
    • Cushing's Disease
    • [11C]-Methionine PET/MRI
    • Bron, France
      Service de Médecine Nucléaire - Hospices Civils de Lyon
    Nov 30, 2020

    Cushing Disease Trial in Worldwide (Pasireotide)

    Completed
    Has Results
    • Cushing Disease
    • Boston, Massachusetts
    • +7 more
    May 6, 2021

    Long-term Cardiovascular Risk in Cured Cushing's Patients

    Terminated
    • Cushing's Disease
      • Boston, Massachusetts
        Neuroendocrine Clinical Center
      Aug 31, 2020

      Cushing's Disease Trial in Los Angeles (rosiglitazone maleate)

      Terminated
      Has Results
      • Cushing's Disease
      • rosiglitazone maleate
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center at UCLA
      Jul 29, 2020

      Cushings Disease, Cushing Disease Trial in Worldwide (LCI699)

      Completed
      Has Results
      • Cushings Disease
      • Cushing Disease
      • Chicago, Illinois
      • +9 more
      Jan 4, 2021

      Cushing Syndrome, Adrenal Insufficiency, Cushing Disease Trial in Roma (circadian gene expression evaluation)

      Unknown status
      • Cushing Syndrome
      • +3 more
      • circadian gene expression evaluation
      • Roma, Italy
        Department of Experimental Medicine, "Sapienza" University of Ro
      Apr 30, 2020

      Seoul National University Pituitary Disease Cohort Study

      Recruiting
      • Pituitary Disease
      • +7 more
      • Dynamic hormone study and Magnetic resonance imaging
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 17, 2020

      Cushing's Disease Trial in Worldwide (osilodrostat, osilodrostat Placebo)

      Completed
      Has Results
      • Cushing's Disease
      • Aurora, Colorado
      • +35 more
      Oct 20, 2021

      Diagnostic Yield of Deep Learning Based Denoising MRI in

      Unknown status
      • Pituitary ACTH Secreting Adenoma
      • MRI
      • Seoul, Korea, Republic of
        Asan Medical Center
      Jan 13, 2020

      Cushing's Disease Complications

      Completed
      • Cushing's Disease
      • Exams and questionnaires
      • Paris, France
        AP-HP, Hôpital Cochin
      Jan 27, 2020